Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01857713 · ClinicalTrials.gov registry record · NA
Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device
A NA study of Laryngopharyngeal Reflux, sponsored by Somna Therapeutics, L.L.C..
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 5
- Study locations
NCT01857713 is a NA study of Laryngopharyngeal Reflux that has completed, run by Somna Therapeutics, L.L.C.. The registered enrollment target is 95 participants, roughly in line with the 92-participant average among 3 other Laryngopharyngeal Reflux trials with a reported enrollment target. The trial reports 5 study locations across 3 states.
The verdict
NCT01857713, a NA study of Laryngopharyngeal Reflux, has completed, sponsored by Somna Therapeutics, L.L.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of the study is to determine the safety and effectiveness of non-invasive Reza Band UES Assist Device for the treatment of esophagopharyngeal reflux with extra-esophageal symptoms (chronic cough, choking, aspiration, chronic post nasal drip, globus, sore throat, throat clearing).
Conditions Studied
Interventions
- DEVICE Reza Band UES Assist Device
Study Locations (5)
New York
- Dr. Alan Raymond - New York
- Madison ENT & Facial Plastic surgery - New York
Wisconsin
- Wisconsin Center for Advanced Research - Milwaukee
- Aurora Health Care - Summit
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01857713
The ClinicalTrials.gov registry entry for NCT01857713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 92-participant average among 3 other Laryngopharyngeal Reflux trials with a reported enrollment target. The listed sponsor is Somna Therapeutics, L.L.C., which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Laryngopharyngeal Reflux appearing as the primary indexed condition, and to 1 intervention - of which Reza Band UES Assist Device is the first listed.
NCT01857713 reports 5 study locations spanning 3 distinct geographic areas - top geographies include New York, Wisconsin, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01857713 about?
NCT01857713 is a clinical study titled "Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device". The purpose of the study is to determine the safety and effectiveness of non-invasive Reza Band UES Assist Device for the treatment of esophagopharyngeal reflux with extra-esophageal symptoms (chronic cough, choking, aspiration, chronic post nasal drip, globus, sore throat, throat clearing).
What is the current status of trial NCT01857713?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2013-04. Estimated completion is 2013-09.
What conditions does trial NCT01857713 study?
This clinical trial studies the following conditions: Laryngopharyngeal Reflux.
What interventions are being tested in trial NCT01857713?
The interventions under investigation include: Reza Band UES Assist Device (DEVICE).
Who is sponsoring clinical trial NCT01857713?
This trial is sponsored by Somna Therapeutics, L.L.C., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01857713 being conducted?
This trial has 5 study locations across New York, Tennessee, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Laryngopharyngeal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.